| Financial Year |
March 31 2023 |
| Monetary Funds |
3,407,332,569.50 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
17,705,641.38 |
| Accounts Receivable |
1,645,519,241.57 |
| Advances to Suppliers |
511,620,114.94 |
| Other Receivables |
129,266,663.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,950,641,233.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
149,232,516.33 |
| Other Current Assets |
75,582,467.88 |
| Total Current Assets |
8,227,871,549.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
14,647,154.69 |
| Long-term Equity Investment |
1,723,725,936.96 |
| Investment Properties |
55,620,623.81 |
| Fixed Assetes |
1,563,341,897.96 |
| Under-construction Projects |
321,509,921.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
306,413,659.28 |
| R&D expenses |
-- |
| Goodwill |
3,380,389.76 |
| Long-Term Deferred and Prepaid Expenses |
11,921,054.99 |
| Deferred Income Tax Assets |
86,258,767.44 |
| Other Non-Current Assets |
14,904,988.05 |
| Sub-Total of Non-Current Assets |
4,187,774,822.03 |
| Total Assets |
12,415,646,371.32 |
| Short-Term Loans |
873,105,755.30 |
| Trading Financial liabilities |
1,969,813.31 |
| Notes Payable |
580,208,122.00 |
| Accounts Payable |
2,131,613,624.58 |
| Accounts Received In Advance |
1,370,772.34 |
| Employee Compensation Payable |
79,456,836.25 |
| Taxes Payable |
144,878,169.83 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
89,507,791.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
20,694,805.84 |
| Other Current Liabilities |
44,942,584.24 |
| Sub-Total of Current Liabilities |
4,258,242,518.18 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
4,578,954.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
18,423,952.88 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
109,003,923.79 |
| Total Liabilities |
4,367,246,441.97 |
| Paid-In Capital(Or Share Stock) |
935,580,035.00 |
| Capital Surplus |
1,782,926,497.49 |
| Surplus Reserve |
559,673,773.25 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,289,569,184.25 |
| Minority Stockholder's Interest |
520,099,647.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,528,300,281.43 |
| Owner's Equity（Stockholder's Equity） |
8,048,399,929.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,415,646,371.32 |
